{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T08:47:14Z","timestamp":1791708434213,"version":"4.3.4"},"reference-count":109,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.hlc.2020.05.101","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T23:19:50Z","timestamp":1591399190000},"page":"973-987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":152,"title":["SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart"],"prefix":"10.1016","volume":"29","author":[{"given":"Bishnu P.","family":"Dhakal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy K.","family":"Sweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia H.","family":"Indik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preethi","family":"William","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.hlc.2020.05.101_bib1","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(20)30129-8","article-title":"Can we contain the COVID-19 outbreak with the same measures as for SARS?","volume":"20","author":"Wilder-Smith","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.hlc.2020.05.101_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u202f314 cases from the Chinese Center for Disease Control and Prevention","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.hlc.2020.05.101_bib3","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","article-title":"Covid-19 in critically ill patients in the Seattle Region \u2014 case series","volume":"382","author":"Bhatraju","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hlc.2020.05.101_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2020.05.101_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"19","key":"10.1016\/j.hlc.2020.05.101_bib6","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1056\/NEJMc2001801","article-title":"Covid-19 in South Korea \u2014 challenges of subclinical manifestations","volume":"382","author":"Song","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.hlc.2020.05.101_bib7","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of Covid-19 in New York City","volume":"382","author":"Goyal","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2020.05.101_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.hlc.2020.05.101_bib9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jchf.2020.03.004","article-title":"COVID-19 illness and heart failure: a missing link?","volume":"8","author":"Mehra","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hlc.2020.05.101_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.hlc.2020.05.101_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.hlc.2020.05.101_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","volume":"109","author":"Li","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hlc.2020.05.101_bib13","article-title":"Clinical characteristics of coronavirus pneumonia 2019 (COVID-19): an updated systematic review","author":"Fang","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.hlc.2020.05.101_bib14","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2020.05.101_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"20","key":"10.1016\/j.hlc.2020.05.101_bib16","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease","volume":"141","author":"Clerkin","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hlc.2020.05.101_bib17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"10.1016\/j.hlc.2020.05.101_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11357-020-00186-0","article-title":"SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes","volume":"42","author":"Nikolich-Zugich","year":"2020","journal-title":"GeroScience"},{"key":"10.1016\/j.hlc.2020.05.101_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.06.003","article-title":"Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters","volume":"128","author":"Kuba","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.hlc.2020.05.101_bib20","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2 and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hlc.2020.05.101_bib21","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic features in severe SARS-CoV-2 infection","volume":"382","author":"Helms","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.hlc.2020.05.101_bib22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","volume":"116","author":"Chen","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hlc.2020.05.101_bib23","first-page":"411","volume":"49","author":"Yao","year":"2020","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.hlc.2020.05.101_bib24","article-title":"Pulmonary and cardiac pathology in Covid-19: the first autopsy series from New Orleans","author":"Fox","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.hlc.2020.05.101_bib25","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2020.05.101_bib26","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.hlc.2020.05.101_bib27","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/eurheartj\/ehaa311","article-title":"Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts","volume":"41","author":"Nicin","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2020.05.101_bib28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2020.05.101_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","article-title":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","volume":"9","author":"Tian","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.hlc.2020.05.101_bib30","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1128\/JCM.41.12.5781-5782.2003","article-title":"Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay","volume":"41","author":"Shi","year":"2003","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.hlc.2020.05.101_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A\u00a0pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.hlc.2020.05.101_bib32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.hlc.2020.05.101_bib33","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/eurheartj\/ehaa235","article-title":"SARS-CoV2: should inhibitors of the renin\u2013angiotensin system be withdrawn in patients with COVID-19?","volume":"41","author":"Kuster","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2020.05.101_bib34","series-title":"HFSA\/ACC\/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19","year":"2020"},{"key":"10.1016\/j.hlc.2020.05.101_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamacardio.2016.0433","article-title":"Seasonal influenza infections and cardiovascular disease mortality","volume":"1","author":"Nguyen","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hlc.2020.05.101_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hlc.2020.05.101_bib37","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ejhf.1828","article-title":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock","volume":"22","author":"Tavazzi","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hlc.2020.05.101_bib38","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2020.05.101_bib39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.hlc.2020.05.101_bib40","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.hlc.2020.05.101_bib41","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2009020","article-title":"ST-segment elevation in patients with Covid-19 \u2014 a case series","author":"Bangalore","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.hlc.2020.05.101_bib42","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2020.05.101_bib43","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1056\/NEJMc2010472","article-title":"Immune thrombocytopenic purpura in a patient with Covid-19","volume":"382","author":"Zulfiqar","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2020.05.101_bib44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.hlc.2020.05.101_bib45","first-page":"1","article-title":"Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series","author":"Wang","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.hlc.2020.05.101_bib46","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth Universal Definition of Myocardial Infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2020.05.101_bib47","article-title":"Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin","author":"Hu","year":"2020","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.hlc.2020.05.101_bib48","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.hlc.2020.05.101_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.pcad.2020.03.001","article-title":"Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis","author":"Lippi","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.hlc.2020.05.101_bib50","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients With 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.hlc.2020.05.101_bib51","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/eurheartj\/ehaa306","article-title":"Typical takotsubo syndrome triggered by SARS-CoV-2 infection","volume":"41","author":"Meyer","year":"2020","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.hlc.2020.05.101_bib52","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/eurheartj\/ehaa286","article-title":"Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection","volume":"41","author":"Sala","year":"2020","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.hlc.2020.05.101_bib53","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/eurheartj\/ehaa288","article-title":"COVID-19-related myocarditis in a 21-year-old female patient","volume":"41","author":"Kim","year":"2020","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.hlc.2020.05.101_bib54","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2020.03.021","article-title":"Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from ACC's Interventional Council and SCAI","volume":"75","author":"Welt","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2020.05.101_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlc.2020.05.003","article-title":"CSANZ position statement on the evaluation of patients presenting with\u00a0suspected acute coronary syndrome during the COVID-19 pandemic","author":"Parsonage","year":"2020","journal-title":"Heart Lung Circ"},{"issue":"9","key":"10.1016\/j.hlc.2020.05.101_bib56","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/CM9.0000000000000744","article-title":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province","volume":"133","author":"Liu","year":"2020","journal-title":"Chinese Med J (Engl)"},{"issue":"22","key":"10.1016\/j.hlc.2020.05.101_bib57","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/eurheartj\/ehaa307","article-title":"Transient complete heart block in a patient with critical COVID-19","volume":"41","author":"Azarkish","year":"2020","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.hlc.2020.05.101_bib58","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2020.05.101_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.hlc.2020.05.101_bib60","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa237","article-title":"In\u00a0vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.hlc.2020.05.101_bib61","doi-asserted-by":"crossref","first-page":"117477","DOI":"10.1016\/j.lfs.2020.117477","article-title":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","volume":"248","author":"Elfiky","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.hlc.2020.05.101_bib62","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A\u00a0trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2020.05.101_bib63","article-title":"Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","author":"Elfiky","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.hlc.2020.05.101_bib64","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.hlc.2020.05.101_bib65","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","author":"Shen","year":"2020323161582","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2020.05.101_bib66","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2020.05.101_bib67","article-title":"Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19","author":"Bhimraj","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.hlc.2020.05.101_bib68","article-title":"No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial","author":"Mahevas","year":"2020","journal-title":"medRxiv"},{"issue":"6","key":"10.1016\/j.hlc.2020.05.101_bib69","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.mayocp.2020.03.024","article-title":"Urgent guidance for navigating and circumventing the QTc prolonging and torsadogenic potential of possible pharmacotherapies for COVID-19","volume":"95","author":"Giudicessi","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.hlc.2020.05.101_bib70","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S2213-2600(20)30172-7","article-title":"Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base","volume":"8","author":"Taccone","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hlc.2020.05.101_bib71","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2125.2000.00197.x","article-title":"Influence of hydroxychloroquine on the bioavailability of oral metoprolol","volume":"49","author":"Somer","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.hlc.2020.05.101_bib72","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.hlc.2020.05.101_bib73","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/1060028016660325","article-title":"Evaluation of a potential interaction between new regimens to treat hepatitis C and warfarin","volume":"50","author":"DeCarolis","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.hlc.2020.05.101_bib74","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/cpt.1099","article-title":"Clopidogrel increases dasabuvir exposure with or without ritonavir, and ritonavir inhibits the bioactivation of clopidogrel","volume":"105","author":"Itkonen","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.hlc.2020.05.101_bib75","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/phar.1477","article-title":"Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety","volume":"34","author":"Dobesh","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.hlc.2020.05.101_bib76","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s40262-018-0637-6","article-title":"Impact of boosted antiretroviral therapy on the pharmacokinetics and efficacy of clopidogrel and prasugrel active metabolites","volume":"57","author":"Marsousi","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.hlc.2020.05.101_bib77","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/bcp.12075","article-title":"Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects","volume":"76","author":"Mueck","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.hlc.2020.05.101_bib78","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s40259-018-0320-3","article-title":"Targeting IL-6 or IL-6 receptor in rheumatoid arthritis: what's the difference?","volume":"32","author":"Avci","year":"2018","journal-title":"BioDrugs"},{"key":"10.1016\/j.hlc.2020.05.101_bib79","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 - preliminary report","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2020.05.101_bib80","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 days in patients with severe covid-19","author":"Goldman","year":"2020","journal-title":"N Engl J Med"},{"issue":"10236","key":"10.1016\/j.hlc.2020.05.101_bib81","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2020.05.101_bib82","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.hlc.2020.05.101_bib83","article-title":"Controversial treatments: an updated understanding of the coronavirus disease 2019","author":"Zhang","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.hlc.2020.05.101_bib84","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13054-019-2316-x","article-title":"The PSG Sequential organ failure assessment score is an excellent operationalization of disease severity of adult patients with hospitalized community acquired pneumonia \u2013 results from the prospective observational PROGRESS study","volume":"23","author":"Ahnert","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.hlc.2020.05.101_bib85","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/CCM.0b013e31819def97","article-title":"The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation","volume":"37","author":"Jones","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.hlc.2020.05.101_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlc.2020.04.003","article-title":"CSANZ imaging council position statement on echocardiography services during the COVID-19 pandemic","author":"Wahi","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2020.05.101_bib87","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4914","article-title":"Management of critically ill adults with COVID-19","author":"Poston","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2020.05.101_bib88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13613-019-0540-9","article-title":"Formal guidelines: management of acute respiratory distress syndrome","volume":"9","author":"Papazian","year":"2019","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.hlc.2020.05.101_bib89","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2020.05.101_bib90","first-page":"244","article-title":"An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: possible benefits of intravenous lidocaine","volume":"6","author":"Mitra","year":"2020","journal-title":"Heart Rhythm Case Rep"},{"key":"10.1016\/j.hlc.2020.05.101_bib91","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCOUTCOMES.113.000152","article-title":"Development and validation of a risk score to predict QT interval prolongation in hospitalized patients","volume":"6","author":"Tisdale","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"10.1016\/j.hlc.2020.05.101_bib92","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.cjca.2020.04.003","article-title":"Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: a statement from the Canadian Heart Rhythm Society","volume":"36","author":"Sapp","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hlc.2020.05.101_bib93","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2020.05.101_bib94","first-page":"e471","volume":"133","author":"Page","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2020.05.101_bib95","first-page":"e272","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2020.05.101_bib96","author":"Lakkireddy","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hlc.2020.05.101_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlc.2020.04.001","article-title":"Position statement on the management of cardiac electrophysiology and cardiac implantable electronic devices in australia during the COVID-19 pandemic: a living document","author":"Kumar","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2020.05.101_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/ccd.28887","article-title":"Considerations for cardiac catheterization laboratory procedures during the COVID-19 pandemic perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Graduates","author":"Szerlip","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.hlc.2020.05.101_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlc.2020.05.001","article-title":"Rural and remote cardiology during the COVID-19 pandemic: CSANZ consensus statement","author":"Arnold","year":"2020","journal-title":"Heart Lung Circ"},{"issue":"22","key":"10.1016\/j.hlc.2020.05.101_bib100","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/eurheartj\/ehaa253","article-title":"Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19","volume":"41","author":"Hua","year":"2020","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hlc.2020.05.101_bib101","doi-asserted-by":"crossref","first-page":"e006631","DOI":"10.1161\/CIRCOUTCOMES.120.006631","article-title":"Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment\u2013elevation myocardial infarction care in Hong Kong, China","volume":"13","author":"Tam","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.hlc.2020.05.101_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlc.2020.04.004","article-title":"Cardiovascular disease in the post-COVID-19 era & the impending tsunami?","author":"Allahwala","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2020.05.101_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlc.2020.04.005","article-title":"COVID-19 and acute heart failure: screening thecritically ill","author":"Lal","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2020.05.101_bib104","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S2213-2600(20)30121-1","article-title":"Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases","volume":"8","author":"Ramanathan","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hlc.2020.05.101_bib105","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hlc.2020.05.101_bib106","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2342","article-title":"Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation","author":"MacLaren","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.hlc.2020.05.101_bib107","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.hlc.2020.03.014","article-title":"Cardiovascular and logistic issues\u00a0associated with COVID-19 pandemic","volume":"29","author":"Denniss","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2020.05.101_bib108","series-title":"Modelling transmission and control of the COVID-19 Pandemic in Australia","author":"Chang","year":"2020"},{"issue":"7","key":"10.1016\/j.hlc.2020.05.101_bib109","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.hlc.2020.04.007","article-title":"Optimising secondary prevention and cardiac rehabilitation for atherosclerotic cardiovascular disease during the COVID-19 pandemic: a position statement from the Cardiac Society of Australia and New Zealand (CSANZ)","volume":"29","author":"Nicholls","year":"2020","journal-title":"Heart Lung Circ"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950620302717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950620302717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T20:44:38Z","timestamp":1731098678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950620302717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":109,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1443950620302717"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2020.05.101","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2020.05.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}